MANGIERI, DOMENICA
 Distribuzione geografica
Continente #
EU - Europa 1.324
NA - Nord America 1.135
AS - Asia 498
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.973
Nazione #
US - Stati Uniti d'America 1.113
IE - Irlanda 490
CN - Cina 354
UA - Ucraina 310
SE - Svezia 250
FR - Francia 88
TR - Turchia 83
IT - Italia 72
FI - Finlandia 53
SG - Singapore 45
DE - Germania 36
CA - Canada 22
GB - Regno Unito 8
BE - Belgio 7
BR - Brasile 5
AU - Australia 4
EU - Europa 4
JP - Giappone 4
HK - Hong Kong 3
IN - India 3
KR - Corea 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RU - Federazione Russa 2
CL - Cile 1
EE - Estonia 1
HU - Ungheria 1
LK - Sri Lanka 1
NL - Olanda 1
PL - Polonia 1
Totale 2.973
Città #
Dublin 490
Jacksonville 219
Chandler 194
Nyköping 190
Dearborn 119
Nanjing 99
New York 65
Princeton 48
Beijing 36
Wilmington 36
Ashburn 33
Ann Arbor 32
Shenyang 32
Nanchang 29
San Mateo 26
Kunming 24
Singapore 24
Hebei 20
Kirkland 16
Albuquerque 15
Tianjin 15
Boardman 14
Changsha 14
Foggia 14
Nuremberg 14
Helsinki 13
Des Moines 11
Kocaeli 11
Lanzhou 10
Guangzhou 9
Los Angeles 9
Ningbo 9
Zhengzhou 9
Jiaxing 8
Jinan 8
Bari 7
Brussels 7
Castellana Grotte 7
Fuzhou 6
Nashville 6
Orange 6
Shanghai 6
Changchun 5
Stevenage 5
São Paulo 5
Hangzhou 4
Sydney 4
Chicago 3
Detroit 3
Hefei 3
Milan 3
Napoli 3
Norwalk 3
Washington 3
Yokohama 3
Baltimore 2
Brno 2
Cedar Knolls 2
Council Bluffs 2
London 2
Neviano degli Arduini 2
Padova 2
Paris 2
Pinheiro de Azere 2
Rende 2
San Francisco 2
Scandiano 2
Taizhou 2
Toronto 2
Atlanta 1
Brescia 1
Budapest 1
Capurso 1
Colombo 1
Cormeilles-en-Parisis 1
Frankfurt am Main 1
Genoa 1
Haikou 1
Houston 1
Istanbul 1
Leeds 1
Mumbai 1
Munich 1
Nürnberg 1
Oakland 1
Parma 1
Philadelphia 1
Phoenix 1
Pinehaven 1
Pune 1
Saint Paul 1
San Jose 1
Saratov 1
Seocho 1
Shatin 1
Siena 1
Taiyuan 1
Tallinn 1
Tokyo 1
Warsaw 1
Totale 2.066
Nome #
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality 127
MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line 88
An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells 83
HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic MDX mouse 82
Angiogenic response induced by acellular aortic matrix in vivo 80
Brain angiogenesis in dystrophic mdx mice is mediated by an increased proteolytic activity and VEGF expression. 79
Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin 76
Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse 76
Altered blood-brain barrier development in dystrophic MDX mice 73
First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant 72
Clodronate inhibits angiogenesis in vitro and in vivo 70
Paving the path for invasion: The polyedric role of LASP1 in cancer 70
Angiogenic response induced by acellular aortic matrix in vivo 69
Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse 69
Evaluation of microvascular density in tumors: pro and contra 69
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 69
Vascular endothelial growth factor-A, vascular endothelial growth factor receptor-2 and angiopoietin-2 expression in the mouse choroid plexuses 68
Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis 68
Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer 67
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma 67
Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma 67
Blood-brain barrier alterations in MDX mouse, an animal model of the Duchenne muscular dystrophy 65
Beta amyloid angiogenic activity in vitro and in vivo 64
Microcirculation density and maturity in uterine and soft tissue leiomyosarcomas: an immunohistochemical study 64
The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets 64
A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice 64
Aquaporin-4 contributes to the resolution of peritumoural brain oedema in human glioblastoma multiforme after combined chemotherapy and radiotherapy 64
Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas 62
Desmin-positive pericytes in the chick embryo chorioallantoic membrane in response to fibroblast growth factor-2 61
Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases 60
Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: A morphological and molecular study 60
Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium 60
Pentoxifylline ameliorates calcium homeostasis re generation in skeletal muscle of dystrophic mdx mice: a comparision with the effects of a combined treatment prednisolone-taurine 58
Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin 57
Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: Preclinical efficacy of the novel, orally available inhibitor dasatinib 55
In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin 54
Neridronate inhibits angiogenesis in vitro and in vivo 54
Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse 53
Role of tumour necrosis factor α, but not of cyclo-oxygenase-2- derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: A pharmacological approach 52
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer 50
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 47
Mast cells contribute to vasculogenic mimicry in multiple myeloma 47
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer 47
Nerve growth factor as an angiogenic factor 46
Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis 41
Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment 40
Paving the path for invasion: The polyedric role of LASP1 in cancer 40
Redox-Dependent Modulation of Human Liver Progenitor Cell Line Fate 33
Piperine: role in prevention and progression of cancer 31
Fibrocytes in Chronic Periaortitis. Nicastro M, Vescovini R, Maritati F, Palmisano A, Urban ML, Incerti M, Fenaroli P, Peyronel F, Benigno GD, Mangieri D, Volpi R, Becchi G, Romagnani P, Corradi D, Vaglio A. Arthritis Rheumatol. 2019 Jun 24. doi: 10.1002/art.41024. [Epub ahead of print] 28
Mechanisms of chemopreventive and therapeutic proprieties of ginger extracts in cancer 25
null 21
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis 6
Totale 3.162
Categoria #
all - tutte 16.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020582 115 51 14 2 67 97 81 16 64 6 65 4
2020/2021366 49 2 55 2 46 2 54 24 64 68 0 0
2021/2022251 31 3 3 0 25 5 7 21 25 35 26 70
2022/20231.191 106 44 72 35 49 109 7 100 561 19 77 12
2023/2024197 24 12 9 7 11 75 2 11 0 10 1 35
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 3.162